LINGO1 is not associated with Parkinson's disease in German patients

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 6, 2010, Pages 1173-1178

  Klebe, Stephan ^a   Thier, Sandra ^a   Lorenz, Delia ^a   Nothnagel, Michael ^b   Schreiber, Stefan ^b   Klein, Christine ^c   Hagenah, Johann ^c   Kasten, Meike ^c   Berg, Daniela ^d   Srulijes, Karin ^d   Gasser, Thomas ^d   Deuschl, Günther ^a   Kuhlenbäumer, Gregor ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Association study; LINGO1; Parkinson disease

Indexed keywords

LINGO1 PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CONTROLLED STUDY; ESSENTIAL TREMOR; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GERMANY; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

RODENTIA;

EID: 77956105396     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31085     Document Type: Article

References (25)

1. Benito-Leon J, Louis ED, Bermejo-Pareja F. 2009. Risk of incident Parkinson's disease and Parkinsonism in essential tremor: A population based study. J Neurol Neurosurg Psychiatry 80(4):423-425.
2. Dupont WD, Plummer WD Jr. 1998. Power and sample size calculations for studies involving linear regression. Control Clin Trials 19(6):589-601. (Pubitemid 29057724)
3. Fung HC, Scholz S, Matarin M, Simon-Sanchez J, Hernandez D, Britton A, Gibbs JR, Langefeld C, Stiegert ML, Schymick J, et al. 2006. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: First stage analysis and public release of data. Lancet Neurol 5(11):911-916.
4. Hampe J, Wollstein A, Lu T, Frevel HJ, Will M, Manaster C, Schreiber S. 2001. An integrated system for high throughput TaqMan based SNP genotyping. Bioinformatics 17(7):654-655. (Pubitemid 32707588)
5. Haubenberger D, Hotzy C, Pirker W, Katzenschlager R, Brucke T, Zimprich F, Auff E, Zimprich A. 2009. Role of LINGO1 polymorphisms in Parkinson's disease. Mov Disord 24(16):2404-2407.
6. Hughes AJ, Daniel SE, Kilford L, Lees AJ. 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181-184.
7. Inoue H, Lin L, Lee X, Shao Z, Mendes S, Snodgrass-Belt P, Sweigard H, Engber T, Pepinsky B, Yang L, et al. 2007. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models. Proc Natl Acad Sci USA 104(36):14430-14435. (Pubitemid 350003278)
8. Ji B, Li M, Wu WT, Yick LW, Lee X, Shao Z, Wang J, So KF, McCoy JM, Pepinsky RB, et al. 2006. LINGO-1 antagonist promotes functional recovery and axonal sprouting after spinal cord injury. Mol Cell Neurosci 33(3):311-320. (Pubitemid 44692494)
9. Krawczak M, Nikolaus S, von Eberstein H, Croucher PJ, El Mokhtari NE, Schreiber S. 2006. PopGen: Population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet 9(1):55-61. (Pubitemid 43289519)
10. Lesage S, Brice A. 2009. Parkinson's disease: From monogenic forms to genetic susceptibility factors. Hum Mol Genet 18(R1):R48-R59.
11. Lesage S, Durr A, Tazir M, Lohmann E, Leutenegger AL, Janin S, Pollak P, Brice A. 2006. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 354(4):422-423. (Pubitemid 43145082)
12. Lu TT, Lao O, Nothnagel M, Junge O, Freitag-Wolf S, Caliebe A, Balascakova M, Bertranpetit J, Bindoff LA, Comas D, et al. 2009. A nevaluation of the genetic-matched pair study design using genome-wide SNP data from the European population. Eur J Hum Genet 17(7):967-975.
13. Maraganore DM, de Andrade M, Lesnick TG, Strain KJ, Farrer MJ, Rocca WA, Pant PV, Frazer KA, Cox DR, Ballinger DG. 2005. High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet 77(5):685-693. (Pubitemid 41513273)
14. Paisan-Ruiz C, Nath P, Washecka N, Gibbs JR, Singleton AB. 2008. Comprehensive analysis of LRRK2 in publicly available Parkinson's disease cases and neurologically normal controls. Hum Mutat 29(4):485-490.
15. Pankratz N, Wilk JB, Latourelle JC, DeStefano AL, Halter C, Pugh EW, Doheny KF, Gusella JF, Nichols WC, Foroud T, et al. 2009. Genomewide association study for susceptibility genes contributing to familial Parkinson disease. Hum Genet 124(6):593-605.
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, et al. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559-575.
17. Shahed J, Jankovic J. 2007. Exploring the relationship between essential tremor and Parkinson's disease. Parkinsonism Relat Disord 13(2):67-76. (Pubitemid 46329516)
18. Stefansson H, Steinberg S, Petursson H, Gustafsson O, Gudjonsdottir IH, Jonsdottir GA, Palsson ST, Jonsson T, Saemundsdottir J, Bjornsdottir G, et al. 2009. Variant in the sequence of the LINGO1 gene confers risk of essential tremor. Nat Genet 41(3):277-279.
19. Steffens M, Lamina C, Illig T, Bettecken T, Vogler R, Entz P, Suk EK, Toliat MR, Klopp N, Caliebe A, et al. 2006. SNP-based analysis of genetic substructure in the German population. Hum Hered 62(1):20-29.
20. Tan EK, Teo YY, Prakash KM, Li R, Lim HQ, Angeles D, Tan LC, Au WL, Yih Y, Zhao Y. 2009. LINGO1 variant increases risk of familial essential tremor. Neurology 73(14):1161-1162.
21. Thacker EL, Ascherio A. 2008. Familial aggregation of Parkinson's disease: A meta-analysis. Mov Disord 23(8):1174-1183.
22. Thier S, Lorenz D, Nothnagel M, Stevanin G, Dürr A, Nebel A, Schreiber S, Kuhlenbäumer G, Deuschl G, Klebe S. 2009. LINGO1 polymorphisms are associated with essential tremor in Europeans. Mov Disord (in press).
23. Vilarino-Guell C, Ross OA, Wider C, Jasinska-Myga B, Cobb SA, Soto-Ortolaza AI, Kachergus JM, Keeling BH, Dachsel JC, Melrose HL, et al. 2010. LINGO1 rs9652490 is associated with essential tremor and Parkinson disease. Parkinsonism Relat Disord 16(2):109-111.
24. Wigginton JE, Cutler DJ, Abecasis GR. 2005. A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76(5):887-893.
25. Wirdefeldt K, Gatz M, Bakaysa SL, Fiske A, Flensburg M, Petzinger GM, Widner H, Lew MF, Welsh M, Pedersen NL. 2008. Complete ascertainment of Parkinson disease in the Swedish Twin Registry. Neurobiol Aging 29(12):1765-1773.